SPRINGWORKS THERAPEUTICS, INC. Proceeds from Common Stock Issued
SPRINGWORKS THERAPEUTICS, INC. reported Proceeds from Common Stock Issued of $0 for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-20.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfCommonStock · last filed 2025-02-20
- SPRINGWORKS THERAPEUTICS, INC. proceeds from issuance of common stock for the quarter ending 2020-12-31 was $269.59M.
- SPRINGWORKS THERAPEUTICS, INC. proceeds from issuance of common stock for the quarter ending 2019-12-31 was $0.00.
- SPRINGWORKS THERAPEUTICS, INC. proceeds from issuance of common stock for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- SPRINGWORKS THERAPEUTICS, INC. proceeds from issuance of common stock for fiscal 2023 was $299.30M.
- SPRINGWORKS THERAPEUTICS, INC. proceeds from issuance of common stock for fiscal 2022 was $0.00.
- SPRINGWORKS THERAPEUTICS, INC. proceeds from issuance of common stock for fiscal 2021 was $0.00, a 100.00% decline from fiscal 2020.
| Period end | Proceeds from Issuance of Common Stock | Proceeds from Issuance of Common Stock 3 month | Proceeds from Issuance of Common Stock 9 month | Proceeds from Issuance of Common Stock 12 month |
|---|---|---|---|---|
| 2024-12-31 | $0.00 10-K · filed 2025-02-20 | |||
| 2023-12-31 | $299.30M 10-K · filed 2025-02-20 | |||
| 2022-12-31 | $0.00 10-K · filed 2025-02-20 | |||
| 2021-12-31 | $0.00 10-K · filed 2024-02-27 | |||
| 2020-12-31 | $269.59M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $269.59M 10-K · filed 2023-02-28 | ||
| 2020-10-13 | $269.50M 10-K · filed 2021-02-25 | |||
| 2020-09-30 | $0.00 10-Q · filed 2020-11-12 | |||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $169.73M 10-K · filed 2022-02-24 | ||
| 2019-09-30 | $169.73M 10-Q · filed 2020-11-12 | |||
| 2018-09-30 | $0.00 10-Q · filed 2019-11-12 |